Bull Harbor Capital LLC purchased a new stake in Ventas, Inc. (NYSE:VTR – Free Report) during the first quarter, according to the company in its most recent filing with the SEC. The firm purchased 11,517 shares of the real estate investment trust’s stock, valued at approximately $942,000.
Several other institutional investors also recently made changes to their positions in the stock. Angeles Wealth Management LLC grew its holdings in shares of Ventas by 4.0% during the 1st quarter. Angeles Wealth Management LLC now owns 3,329 shares of the real estate investment trust’s stock worth $274,000 after purchasing an additional 128 shares during the period. Bridgewater Advisors Inc. raised its holdings in Ventas by 2.0% in the fourth quarter. Bridgewater Advisors Inc. now owns 6,790 shares of the real estate investment trust’s stock valued at $525,000 after buying an additional 133 shares during the period. IHT Wealth Management LLC lifted its position in Ventas by 3.2% during the fourth quarter. IHT Wealth Management LLC now owns 4,415 shares of the real estate investment trust’s stock valued at $343,000 after buying an additional 137 shares in the last quarter. Cigna Investments Inc. New lifted its position in Ventas by 3.3% during the fourth quarter. Cigna Investments Inc. New now owns 4,396 shares of the real estate investment trust’s stock valued at $341,000 after buying an additional 142 shares in the last quarter. Finally, Sequoia Financial Advisors LLC grew its stake in Ventas by 1.2% during the first quarter. Sequoia Financial Advisors LLC now owns 12,894 shares of the real estate investment trust’s stock worth $1,054,000 after buying an additional 148 shares during the period. 94.18% of the stock is owned by hedge funds and other institutional investors.
Ventas News Roundup
Here are the key news stories impacting Ventas this week:
- Positive Sentiment: Ventas reported second-quarter funds from operations (FFO) of $0.97 per share, ahead of the $0.96 consensus estimate and up from $0.87 a year earlier. Revenue rose 21.7% year over year to $1.72 billion, exceeding the $1.68 billion forecast. Ventas Beats Q2 FFO and Revenue Estimates
- Positive Sentiment: Strong growth in Ventas’s Senior Housing Operating Portfolio (SHOP) lifted net operating income, while favorable senior-housing demand and new investments supported management’s decision to raise its full-year 2026 FFO guidance. Ventas Q2 FFO and Revenues Beat Estimates on Strong SHOP Growth
- Positive Sentiment: CEO Debra Cafaro highlighted continued enterprise momentum and an opportunity to capture demographic-driven demand through organic growth and external investments in senior housing. Ventas Reports 2026 Second Quarter Results
- Neutral Sentiment: The earnings beat was modest on an FFO-per-share basis, and the shares had already reached a new one-year high, potentially limiting near-term upside as investors lock in gains. Ventas Reaches New One-Year High
Insider Transactions at Ventas
Wall Street Analyst Weigh In
Several equities research analysts have recently issued reports on the stock. Wells Fargo & Company increased their price objective on shares of Ventas from $93.00 to $96.00 and gave the stock an “overweight” rating in a research report on Monday, June 1st. Royal Bank Of Canada upped their price target on shares of Ventas from $91.00 to $98.00 and gave the stock an “outperform” rating in a research report on Monday, May 4th. Deutsche Bank Aktiengesellschaft reiterated a “buy” rating and issued a $100.00 price target on shares of Ventas in a report on Tuesday, June 16th. Citigroup raised their price objective on Ventas from $96.00 to $100.00 and gave the company a “buy” rating in a research report on Friday, May 1st. Finally, KeyCorp boosted their price objective on Ventas from $90.00 to $95.00 and gave the stock an “overweight” rating in a research note on Thursday, May 7th. Fifteen equities research analysts have rated the stock with a Buy rating and four have issued a Hold rating to the company’s stock. According to MarketBeat.com, Ventas presently has a consensus rating of “Moderate Buy” and a consensus price target of $96.50.
Read Our Latest Stock Report on Ventas
Ventas Stock Down 5.8%
VTR stock opened at $92.10 on Friday. The company has a debt-to-equity ratio of 0.95, a current ratio of 0.25 and a quick ratio of 0.25. Ventas, Inc. has a 1-year low of $65.82 and a 1-year high of $101.60. The firm has a fifty day moving average price of $88.87 and a two-hundred day moving average price of $85.52. The firm has a market cap of $44.78 billion, a price-to-earnings ratio of 170.55, a PEG ratio of 2.10 and a beta of 0.70.
Ventas (NYSE:VTR – Get Free Report) last posted its quarterly earnings results on Monday, April 27th. The real estate investment trust reported $0.11 EPS for the quarter, missing the consensus estimate of $0.12 by ($0.01). Ventas had a net margin of 4.08% and a return on equity of 2.06%. The business had revenue of $1.65 billion during the quarter, compared to analyst estimates of $1.59 billion. During the same period last year, the firm posted $0.84 earnings per share. The company’s quarterly revenue was up 22.0% on a year-over-year basis. Research analysts predict that Ventas, Inc. will post 3.88 EPS for the current year.
Ventas Dividend Announcement
The firm also recently announced a quarterly dividend, which was paid on Thursday, July 16th. Shareholders of record on Tuesday, June 30th were issued a $0.52 dividend. The ex-dividend date of this dividend was Tuesday, June 30th. This represents a $2.08 dividend on an annualized basis and a yield of 2.3%. Ventas’s dividend payout ratio (DPR) is currently 378.18%.
Ventas Profile
Ventas, Inc (NYSE: VTR) is a real estate investment trust (REIT) that specializes in healthcare-related real estate. The company acquires, owns and manages a diversified portfolio of properties serving the healthcare continuum, including senior housing communities, skilled nursing facilities, medical office buildings, life science and research centers, and other properties leased to healthcare providers and operators. Ventas generates revenue through long-term leases, property management and selective development activities focused on meeting the real estate needs of the healthcare sector.
Ventas’ business model combines property ownership with active asset management and capital markets activity.
Read More
- Five stocks we like better than Ventas
- Microsoft Just Flipped the AI Spending Narrative Overnight
- Qualcomm’s Turnaround Is Working, So Why Is Wall Street Selling?
- Meta’s Earnings Show Why Wall Street Is Losing Patience With AI Spending
- Can Starbucks Keep This Turnaround Going? The Latest Results Say Yes
Receive News & Ratings for Ventas Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ventas and related companies with MarketBeat.com's FREE daily email newsletter.
